Board of Scientific Counselors, National Center for Environmental Health/Agency for Toxic Substances and Disease Registry (BSC, NCEH/ATSDR), 42329-42330 [2014-17059]
Download as PDF
<![CDATA[
42329
Federal Register / Vol. 79, No. 139 / Monday, July 21, 2014 / Notices
National ART Surveillance System
(NASS), includes information about all
ART cycles initiated by any of the ART
programs in the United States. An ART
cycle is considered to be initiated when
a woman begins taking ovarian
stimulatory drugs or starts ovarian
monitoring with the intent of
transferring one or more embryos. CDC
also collects information about the
pregnancy outcome of each cycle, as
well as a number of data items deemed
important to explain variability in
success rates across ART programs and
across individuals.
Each ART program reports its annual
ART cycle data to CDC in midDecember. The annual data reporting
consists of information about all ART
cycles that were initiated in the
previous calendar year. For example,
the December 2013 reports described
ART cycles that were initiated between
January 1, 2012, and December 31, 2012.
Data elements and definitions currently
in use reflect CDC’s prior consultations
with representatives of the Society for
Assisted Reproductive Technology
(SART), the American Society for
Reproductive Medicine, and RESOLVE:
the National Infertility Association (a
national, nonprofit consumer
organization), as well as a variety of
individuals with expertise and interest
in this field.
CDC, the data collection contractor,
and partner organizations engage in
be deferred until January 1, 2016.
During the period of this revision, the
estimated number of respondents (ART
programs or clinics) will increase from
440 to 450; the estimated number of
ART cycles reported by each clinic will
increase from 339 to 360; and the
estimated burden per response will
increase from 39 minutes to 40 minutes.
In addition, respondents may provide
feedback to CDC about the usability and
utility of the reporting system. The
option to participate in the feedback
survey is presented to respondents
when they complete their required data
submission. However, participation in
the feedback survey is voluntary and is
not required by the FCSRCA. CDC
estimates that 75% of ART programs
will participate in the feedback survey.
The collection of ART cycle
information allows CDC to publish an
annual report to Congress as specified
by the FCSRCA and to provide
information needed by consumers.
Overall, the proposed changes will
support CDC’s ability to generate timely,
accurate, and relevant information about
fertility clinic success rates and improve
user satisfaction with the NASS
interface.
OMB approval is requested for three
years and there are no costs to
respondents other than their time.
ongoing dialogue to identify
opportunities for improvement. As a
result of these discussions, a number of
changes to the NASS data elements and
the NASS reporting platform are under
consideration and will be submitted to
OMB for approval. Changes to the NASS
data elements are essential to keep pace
with changes in medical practice,
ensure that reported success rates reflect
standardized definitions, and provide
additional insight into factors that may
affect success rates. Specific changes to
the NASS data elements include the
addition of new items as well as
modification or discontinuation of
selected items. CDC also plans to
redesign the graphical interface for
NASS. In addition to reflecting the
changes in data items, NASS data entry
pages will be redesigned for more
intuitive grouping of data items and will
employ embedded skip logic to route
users to the minimum number of
applicable questions. Respondents will
have the option of entering data directly
into the Web-based NASS interface or of
transmitting system-compatible files
extracted from other record systems. On
an annual basis, approximately ten
percent of responding clinics are also
selected to participate in data validation
and quality control activities.
Implementation of these changes for
ART cycles initiated on or after January
1, 2015, is under consideration, but may
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total
burden
hours
Type of respondent
Form name
ART Programs ..................................
NASS ................................................
Feedback Survey .............................
450
338
360
1
40/60
2/60
108,000
11
Total ...........................................
...........................................................
........................
........................
........................
108,011
Leroy Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2014–17033 Filed 7–18–14; 8:45 am]
Board of Scientific Counselors,
National Center for Environmental
Health/Agency for Toxic Substances
and Disease Registry (BSC, NCEH/
ATSDR)
emcdonald on DSK67QTVN1PROD with NOTICES
BILLING CODE 4163–18–P
Centers for Disease Control and
Prevention
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following teleconference
meeting of the aforementioned
committee:
VerDate Mar<15>2010
17:14 Jul 18, 2014
Jkt 232001
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
Time And Date: 2:00 p.m.–4:00 p.m.,
August 11, 2014.
Place: Teleconference.
Status: Open to the public, limited only by
the conference lines available. The toll-free,
dial-in number is 1–877–315–6535 and the
passcode is 383520.
Purpose: The Secretary, Department of
Health and Human Services (HHS) and by
delegation, the Director, CDC and
Administrator, NCEH/ATSDR, are authorized
under Section 301(42 U.S.C. 241) and Section
311(42 U.S.C. 243) of the Public Health
Service Act, as amended, to: (1) Conduct,
encourage, cooperate with, and assist other
appropriate public authorities, scientific
institutions, and scientists in the conduct of
research, investigations, experiments,
demonstrations, and studies relating to the
causes, diagnosis, treatment, control, and
prevention of physical and mental diseases
E:\FR\FM\21JYN1.SGM
21JYN1
42330
Federal Register / Vol. 79, No. 139 / Monday, July 21, 2014 / Notices
and other impairments; (2) assist states and
their political subdivisions in the prevention
of infectious diseases and other preventable
conditions and in the promotion of health
and well being; and (3) train state and local
personnel in health work. The BSC, NCEH/
ATSDR provides advice and guidance to the
Secretary, HHS; the Director, CDC and
Administrator, ATSDR; and the Director,
NCEH/ATSDR, regarding program goals,
objectives, strategies, and priorities in
fulfillment of the agency’s mission to protect
and promote people’s health. The board
provides advice and guidance that will assist
NCEH/ATSDR in ensuring scientific quality,
timeliness, utility, and dissemination of
results. The board also provides guidance to
help NCEH/ATSDR work more efficiently
and effectively with its various constituents
and to fulfill its mission in protecting
America’s health.
Matter For Discussion: The agenda item for
the BSC Meeting will include a discussion on
establishing a subcommittee to the BSC on
Childhood Lead Poisoning Prevention.
Agenda item is subject to change as
priorities dictate.
Supplemental Information: The public is
welcome to participate during the public
comment period, tentatively scheduled on
August 11, 2014, from 3:15 p.m., until 3:25
p.m.
Contact Person For More Information:
Sandra Malcom, Committee Management
Specialist, NCEH/ATSDR, CDC, 4770 Buford
Highway, Mail Stop F–61, Chamblee, Georgia
30345; Telephone: 770/488–0575 or 770/
488–0755, Fax: 770/488–3377; Email:
smalcom@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention (CDC).
[FR Doc. 2014–17059 Filed 7–18–14; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
emcdonald on DSK67QTVN1PROD with NOTICES
Board of Scientific Counselors,
National Center for Injury Prevention
and Control, (BSC, NCIPC)
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub.L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting of the
aforementioned committee:
Time and Date: 2:00 p.m.–3:00 p.m.,
August 11, 2014 (CLOSED).
Place: Teleconference.
VerDate Mar<15>2010
17:14 Jul 18, 2014
Jkt 232001
Status: The meeting as designated above
will be closed to the public in accordance
with provisions set forth in Section
552b(c)(4) and (6), Title 5, U.S.C., and the
Determination of the Director, Management
Analysis and Services Office, CDC pursuant
to Public Law 92–463.
Purpose: The Board of Scientific
Counselors makes recommendations
regarding policies, strategies, objectives, and
priorities; and reviews progress toward injury
prevention goals and provides evidence in
injury prevention-related research and
programs. The Board also provides advice on
the appropriate balance of intramural and
extramural research, as well as the structure,
progress, and performance of intramural
programs. The Board is designed to provide
guidance on extramural scientific program
matters, including the: (1) Review of
extramural research concepts for funding
opportunity announcements; (2) conduct of
Secondary Peer Review of extramural
research grants, cooperative agreements, and
contracts applications received in response to
funding opportunity announcements, in
relation to the Center’s programmatic balance
and mission; (3) submission of secondary
review recommendations to the Center
Director of applications to be considered for
funding support; (4) review of research
portfolios, and (5) review of program
proposals.
Matters For Discussion: The Board of
Scientific Counselors, National Center for
Injury Prevention and Control (BSC, NCIPC)
will meet to conduct a Secondary Peer
Review of an extramural research grant
application received in response to Funding
Opportunity Announcement (FOA)
Evaluating Promising Strategies to Build the
Evidence Base for Sexual Violence
Prevention, CE14–005. The application will
be assessed for applicability to the Center’s
mission and programmatic balance.
Recommendations from the secondary review
will be voted upon and the application will
be forwarded to the Acting Center Director
for consideration for funding support.
Contact Person for More Information:
Gwendolyn H. Cattledge, Ph.D., M.S.E.H.,
Deputy Associate Director for Science,
NCIPC, CDC, 4770 Buford Highway NE.,
Mailstop F–63, Atlanta, Georgia 30341,
Telephone (770) 488–1430.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2014–17058 Filed 7–18–14; 8:45 am]
BILLING CODE 4163–18–P
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Committee on Immunization
Practices (ACIP)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC) announce
the following meeting of the
aforementioned committee.
Time and Date: 2:00 p.m.–4:30 p.m. EDT,
August 13, 2014.
Place: Teleconference.
Status: This meeting is open to the public,
limited only by the availability of telephone
ports and webinar.
Participants can join the event directly at:
https://www.mymeetings.com/nc/join.php?i=
PW7936898&p=5994905&t=c. USA
Telephone Dial-in number: 1–800–369–1780.
Participant passcode: 5994905 or URL:
https://www.mymeetings.com/nc/join/.
Conference number: PW7936898.
Audience passcode: 5994905.
Purpose: The committee is charged with
advising the Director, CDC, on the
appropriate use of immunizing agents. In
addition, under 42 U.S.C. 1396s, the
committee is mandated to establish and
periodically review and, as appropriate,
revise the list of vaccines for administration
to vaccine-eligible children through the
Vaccines for Children (VFC) program, along
with schedules regarding the appropriate
periodicity, dosage, and contra-indications
applicable to the vaccines. Further, under
provisions of the Affordable Care Act, at
section 2713 of the Public Health Service
Act, immunization recommendations of the
ACIP that have been adopted by the Director
of the Centers for Disease Control and
Prevention must be covered by applicable
health plans.
Matters for Discussion: The agenda will
include discussions on: Use of 13-valent
pneumococcal conjugate vaccine and 23valent pneumococcal polysaccharide vaccine
in adults 65 years of age and older. A
recommendation vote is scheduled. Time
will be available for public comment.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Stephanie B. Thomas, National Center for
Immunization and Respiratory Diseases,
CDC, 1600 Clifton Road, NE., MS–A27,
Atlanta, Georgia 30333, telephone 404/639–
8836; Email ACIP@CDC.GOV.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities for
both the Centers for Disease Control and
E:\FR\FM\21JYN1.SGM
21JYN1
]]>Agencies
[Federal Register Volume 79, Number 139 (Monday, July 21, 2014)]
[Notices]
[Pages 42329-42330]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-17059]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Board of Scientific Counselors, National Center for Environmental
Health/Agency for Toxic Substances and Disease Registry (BSC, NCEH/
ATSDR)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC), announces the following teleconference meeting of the
aforementioned committee:
Time And Date: 2:00 p.m.-4:00 p.m., August 11, 2014.
Place: Teleconference.
Status: Open to the public, limited only by the conference lines
available. The toll-free, dial-in number is 1-877-315-6535 and the
passcode is 383520.
Purpose: The Secretary, Department of Health and Human Services
(HHS) and by delegation, the Director, CDC and Administrator, NCEH/
ATSDR, are authorized under Section 301(42 U.S.C. 241) and Section
311(42 U.S.C. 243) of the Public Health Service Act, as amended, to:
(1) Conduct, encourage, cooperate with, and assist other appropriate
public authorities, scientific institutions, and scientists in the
conduct of research, investigations, experiments, demonstrations,
and studies relating to the causes, diagnosis, treatment, control,
and prevention of physical and mental diseases
[[Page 42330]]
and other impairments; (2) assist states and their political
subdivisions in the prevention of infectious diseases and other
preventable conditions and in the promotion of health and well
being; and (3) train state and local personnel in health work. The
BSC, NCEH/ATSDR provides advice and guidance to the Secretary, HHS;
the Director, CDC and Administrator, ATSDR; and the Director, NCEH/
ATSDR, regarding program goals, objectives, strategies, and
priorities in fulfillment of the agency's mission to protect and
promote people's health. The board provides advice and guidance that
will assist NCEH/ATSDR in ensuring scientific quality, timeliness,
utility, and dissemination of results. The board also provides
guidance to help NCEH/ATSDR work more efficiently and effectively
with its various constituents and to fulfill its mission in
protecting America's health.
Matter For Discussion: The agenda item for the BSC Meeting will
include a discussion on establishing a subcommittee to the BSC on
Childhood Lead Poisoning Prevention.
Agenda item is subject to change as priorities dictate.
Supplemental Information: The public is welcome to participate
during the public comment period, tentatively scheduled on August
11, 2014, from 3:15 p.m., until 3:25 p.m.
Contact Person For More Information: Sandra Malcom, Committee
Management Specialist, NCEH/ATSDR, CDC, 4770 Buford Highway, Mail
Stop F-61, Chamblee, Georgia 30345; Telephone: 770/488-0575 or 770/
488-0755, Fax: 770/488-3377; Email: smalcom@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities for both the Centers for Disease Control and Prevention
and the Agency for Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention (CDC).
[FR Doc. 2014-17059 Filed 7-18-14; 8:45 am]
BILLING CODE 4163-18-P
